Tolebrutinib

ATC L04AA62 · 3 markets · 4 records

Tolebrutinib 3 markets · 4 records Forms

AU 2 records · 2 strengths

60 mgtabletCENRIFKI tolebrutinib 60mg film coated tablet blister pack unknown

Records without a stated strength · 1 CENRIFKI

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 CENRIFKI

Side-by-side table

Strength / form / release	AU	EU
60 mg tablet	CENRIFKI tolebrutinib 60mg film coated tablet blister pack	not recorded
not disclosed unknown	CENRIFKI	CENRIFKI

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.